+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Dry Eye Medication Market - Global Forecast 2025-2030 - Product Thumbnail Image

Dry Eye Medication Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Bio-Pharma Market 2025-2029 - Product Thumbnail Image

Bio-Pharma Market 2025-2029

  • Report
  • June 2025
  • 229 Pages
  • Global
From
From
From
From
Stem Cell Therapy Market Report and Forecast 2025-2034 - Product Thumbnail Image

Stem Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Alpha Glucosidase Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

Alpha Glucosidase Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
From
Regenerative Medicine Market in Japan 2025-2029 - Product Thumbnail Image

Regenerative Medicine Market in Japan 2025-2029

  • Report
  • February 2025
  • 167 Pages
  • Japan
From
Oral Proteins & Peptides Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Proteins & Peptides Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
Heart Failure Software Market - Global Forecast 2025-2030 - Product Thumbnail Image

Heart Failure Software Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • September 2025
  • 184 Pages
  • Global
From
Clostridium Difficile Treatment - Global Strategic Business Report - Product Thumbnail Image

Clostridium Difficile Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 192 Pages
  • Global
From
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 193 Pages
  • Global
From
Aspergillosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Aspergillosis Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 373 Pages
  • Global
From
Antifungal Treatment - Global Strategic Business Report - Product Thumbnail Image

Antifungal Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 590 Pages
  • Global
From
Loading Indicator